Jianhu Medical key facts
as of Oct 2026- Provider of cardiac interventional ablation surgical solutions intended for the field of cardiac electrophysiology.
- Jianhu Medical is valued at approximately $94.1M as of Oct 2026 (last reported valuation).
- It has raised $20.9M; the latest was Early Stage VC ($20.9M) in Jul 2025.
- Notable investors include Kunshan Industrial Technology Research Institute, Lifetech Scientific, Realharmony Capital, Shanghai Creation Investment Management.
- Status: Privately Held (backing).
Jianhu Medical's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch Jianhu Medical: the Monday email on marks, rounds and moves
Jianhu Medical funding rounds
No funding rounds for Jianhu Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Jianhu Medical valuation
Jianhu Medical's last reported valuation was $94.1 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Jianhu Medical investors
4 investors are on record for Jianhu Medical, including Kunshan Industrial Technology Research Institute, Lifetech Scientific, Realharmony Capital and Shanghai Creation Investment Management.
About Jianhu Medical
Provider of cardiac interventional ablation surgical solutions intended for the field of cardiac electrophysiology. The company focuses on innovative interventional imaging technologies and creates complete cardiac electrophysiology solutions through the integrated strategy of imaging platform, energy platform and consumables, providing clients with innovative cardiac electrophysiological diagnosis and treatment technology.
- Sector
- Healthcare
- HQ
- Kunshan, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.